Literature DB >> 1829775

Diagnostic significance of hypocomplementemia.

L A Hebert, F G Cosio, J C Neff.   

Abstract

Hypocomplementemia is an important marker for the presence of IC-mediated disease and can be used to assess disease activity. However, in interpreting the clinical significance of hypocomplementemia, the following must be kept in mind: 1) There are numerous non-immunologic conditions that also can cause hypocomplementemia. Furthermore, some of these conditions can cause a multisystem disease that, along with the hypocomplementemia, can closely resemble an IC-mediated systemic vasculitis. Furthermore, these nonimmunologic conditions that lower serum complement levels can complicate the course of patients with inactive IC-mediated disease, spuriously indicating that the disease is active. The most relevant of these differential diagnostic problems are listed in Table 2. 2) There are a few conditions (for example, pregnancy) that can raise serum complement levels, thereby possibly obscuring the presence of a disorder (such as, active SLE) that is lowering complement levels. 3) There are some conditions that might be expected to lower serum complement levels, because of their effect on protein metabolism, but do not. Nephrotic syndrome, and moderately poor nutrition are examples. All of these factors should be considered when interpreting results of serum complement levels in a given patient.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1829775     DOI: 10.1038/ki.1991.102

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  19 in total

Review 1.  Complement and the Kidney: An Overview.

Authors:  Joshua M Thurman
Journal:  Adv Chronic Kidney Dis       Date:  2020-03       Impact factor: 3.620

2.  Long-term follow-up of juvenile acute nonproliferative glomerulitis (JANG).

Authors:  Teruo Fujita; Kandai Nozu; Kazumoto Iijima; Ichiro Kamioka; Hiroshi Kaito; Ryojiro Tanaka; Koichi Nakanishi; Masafumi Matsuo; Norishige Yoshikawa
Journal:  Pediatr Nephrol       Date:  2007-08-03       Impact factor: 3.714

Review 3.  Nephrology, dialysis and transplantation.

Authors:  K Farrington; P Sweny
Journal:  Postgrad Med J       Date:  1993-07       Impact factor: 2.401

Review 4.  Systemic lupus erythematosus biomarkers: the challenging quest.

Authors:  Cristina Arriens; Jonathan D Wren; Melissa E Munroe; Chandra Mohan
Journal:  Rheumatology (Oxford)       Date:  2017-04-01       Impact factor: 7.580

5.  Diffuse mesangial and endocapillary cell proliferative glomerulonephritis with persistent hypocomplementemia in a child.

Authors:  Jun-Mei Xu; Rong Wang
Journal:  Int J Clin Exp Med       Date:  2015-09-15

6.  Long-term follow-up of atypical membranoproliferative glomerulonephritis: are steroids indicated?

Authors:  Teruo Fujita; Kandai Nozu; Kazumoto Iijima; Ichiro Kamioka; Kunihiko Yoshiya; Ryojiro Tanaka; Kiyoshi Hamahira; Koichi Nakanishi; Norishige Yoshikawa; Masafumi Matsuo
Journal:  Pediatr Nephrol       Date:  2005-10-25       Impact factor: 3.714

7.  Molecular basis of complete complement C4 deficiency in two North-African families with systemic lupus erythematosus.

Authors:  Y L Wu; G Hauptmann; M Viguier; C Y Yu
Journal:  Genes Immun       Date:  2009-03-12       Impact factor: 2.676

Review 8.  All Things Complement.

Authors:  Joshua M Thurman; Carla M Nester
Journal:  Clin J Am Soc Nephrol       Date:  2016-06-23       Impact factor: 8.237

9.  Glomerular injury in end-stage liver disease--role of circulating IgG and IgM immune complexes.

Authors:  L S Milner; M T Houser; P C Kolbeck; D L Antonson; T L McDonald; R S Markin; B W Shaw
Journal:  Pediatr Nephrol       Date:  1993-02       Impact factor: 3.714

10.  Inhibition of complement C1s in patients with cold agglutinin disease: lessons learned from a named patient program.

Authors:  Georg Gelbenegger; Christian Schoergenhofer; Ulla Derhaschnig; Nina Buchtele; Christian Sillaber; Michael Fillitz; Thomas M Schenk; Shirley D'Sa; Ronwyn Cartwright; James C Gilbert; Bernd Jilma; Ulrich Jaeger
Journal:  Blood Adv       Date:  2020-03-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.